메뉴 건너뛰기




Volumn 376, Issue 9738, 2010, Pages 340-345

Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μl in Europe and North America: A pooled cohort observational study

(328)  Lodwick, Rebecca K a,b   Sabin, Caroline A a,c,s   Porter, K a,s,ay   Ledergerber, B a   Van Sighem, Ard f   Cozzi Lepri, A s   Khaykin, P s   Mocroft, Amanda h   Jacobson, L P i,ai   De Wit, Stephane j,s   Obel, N s   Castagna, A s   Wasmuth, J C s   Gill, John m,s   Klein, Marina B m   Gange, S s   Riera, M ar   Mussini, C s   Gutierrez F w   Touloumi, Giota q,s,v   more..

g ICONA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

EID: 77955716641     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60932-4     Document Type: Article
Times cited : (75)

References (23)
  • 2
    • 85062055676 scopus 로고    scopus 로고
    • Liver-related deaths in persons infected with the human immunodeficiency virus: The D:A:D study
    • R Weber, CA Sabin, N Friis-Møller Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study Arch Intern Med 166 2006 1632 1641
    • (2006) Arch Intern Med , vol.166 , pp. 1632-1641
    • Weber, R.1    Sabin, C.A.2    Friis-Møller, N.3
  • 3
    • 33745078633 scopus 로고    scopus 로고
    • Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion
    • C Smit, R Geskus, S Walker Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion AIDS 20 2006 741 749
    • (2006) AIDS , vol.20 , pp. 741-749
    • Smit, C.1    Geskus, R.2    Walker, S.3
  • 4
    • 57349124803 scopus 로고    scopus 로고
    • The role of HIV in serious diseases other than AIDS
    • AN Phillips, J Neaton, JD Lundgren The role of HIV in serious diseases other than AIDS AIDS 22 2008 2409 2418
    • (2008) AIDS , vol.22 , pp. 2409-2418
    • Phillips, A.N.1    Neaton, J.2    Lundgren, J.D.3
  • 5
    • 38949104111 scopus 로고    scopus 로고
    • European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults
    • N Clumeck, A Pozniak, F Raffi European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults HIV Med 9 2008 65 71
    • (2008) HIV Med , vol.9 , pp. 65-71
    • Clumeck, N.1    Pozniak, A.2    Raffi, F.3
  • 6
    • 48949097660 scopus 로고    scopus 로고
    • Antiretroviral treatment of adult HIV infection - 2008 recommendations of the International AIDS Society USA panel
    • SM Hammer, JJ Eron, P Reiss Antiretroviral treatment of adult HIV infection - 2008 recommendations of the International AIDS Society USA panel JAMA 300 2008 555 570
    • (2008) JAMA , vol.300 , pp. 555-570
    • Hammer, S.M.1    Eron, J.J.2    Reiss, P.3
  • 7
    • 64349118898 scopus 로고    scopus 로고
    • Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: A collaborative analysis of 18 HIV cohort studies
    • JAC Sterne, M May, D Costagliola Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies Lancet 373 2009 1352 1363
    • (2009) Lancet , vol.373 , pp. 1352-1363
    • Sterne, J.A.C.1    May, M.2    Costagliola, D.3
  • 8
    • 65449167169 scopus 로고    scopus 로고
    • Effect of early versus deferred antiretroviral therapy for HIV on survival
    • MM Kitahata, SJ Gange, AG Abraham Effect of early versus deferred antiretroviral therapy for HIV on survival N Engl J Med 360 2009 1815 1826
    • (2009) N Engl J Med , vol.360 , pp. 1815-1826
    • Kitahata, M.M.1    Gange, S.J.2    Abraham, A.G.3
  • 9
    • 42549121220 scopus 로고    scopus 로고
    • Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study
    • S Emery, JA Neuhaus, AN Phillips Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study J Infect Dis 197 2008 1133 1144
    • (2008) J Infect Dis , vol.197 , pp. 1133-1144
    • Emery, S.1    Neuhaus, J.A.2    Phillips, A.N.3
  • 10
    • 4344568424 scopus 로고    scopus 로고
    • HIV cohort collaborations: Proposal for harmonization of data exchange
    • J Kjaer, B Ledergerber HIV cohort collaborations: proposal for harmonization of data exchange Antivir Ther 9 2004 631 633
    • (2004) Antivir Ther , vol.9 , pp. 631-633
    • Kjaer, J.1    Ledergerber, B.2
  • 11
    • 33645034362 scopus 로고    scopus 로고
    • Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia
    • E Lloyd-Smith, E Brodkin, E Wood Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia AIDS 20 2006 445 450
    • (2006) AIDS , vol.20 , pp. 445-450
    • Lloyd-Smith, E.1    Brodkin, E.2    Wood, E.3
  • 12
    • 34247170809 scopus 로고    scopus 로고
    • Success of clinical care for human immunodeficiency virus infection according to demographic group among sexually infected patients in a routine clinic population, 1999 to 2004
    • FC Lampe, CJ Smith, S Madge Success of clinical care for human immunodeficiency virus infection according to demographic group among sexually infected patients in a routine clinic population, 1999 to 2004 Arch Intern Med 167 2007 692 700
    • (2007) Arch Intern Med , vol.167 , pp. 692-700
    • Lampe, F.C.1    Smith, C.J.2    Madge, S.3
  • 14
    • 1642374511 scopus 로고    scopus 로고
    • Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era
    • CASCADE Collaboration P.
    • A Phillips, P Pezzotti CASCADE Collaboration Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era AIDS 18 2004 51 58
    • (2004) AIDS , vol.18 , pp. 51-58
    • Phillips, A.1    Pezzotti, P.2
  • 15
    • 34547818276 scopus 로고    scopus 로고
    • Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count
    • AN Phillips, B Gazzard, R Gilson Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count AIDS 21 2007 1717 1721
    • (2007) AIDS , vol.21 , pp. 1717-1721
    • Phillips, A.N.1    Gazzard, B.2    Gilson, R.3
  • 16
    • 40049091644 scopus 로고    scopus 로고
    • Earlier initiation of antiretroviral therapy in treatment-naive patients: Implications of results of treatment interruption trials
    • JD Neaton, B Grund Earlier initiation of antiretroviral therapy in treatment-naive patients: implications of results of treatment interruption trials Curr Opin HIV AIDS 3 2008 112 117
    • (2008) Curr Opin HIV AIDS , vol.3 , pp. 112-117
    • Neaton, J.D.1    Grund, B.2
  • 17
    • 69449086261 scopus 로고    scopus 로고
    • Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy
    • B Marin, R Thiebaut, H Bucher Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy AIDS 23 2009 1743 1753
    • (2009) AIDS , vol.23 , pp. 1743-1753
    • Marin, B.1    Thiebaut, R.2    Bucher, H.3
  • 18
    • 34948835174 scopus 로고    scopus 로고
    • 3 on long-term combination antiretroviral therapy reach same mortality rates as the general population
    • 3on long-term combination antiretroviral therapy reach same mortality rates as the general population J Acquir Immune Defic Syndr 46 2007 72 77
    • (2007) J Acquir Immune Defic Syndr , vol.46 , pp. 72-77
    • Lewden, C.1    Chene, G.2    Morlat, P.3
  • 19
    • 25844433663 scopus 로고    scopus 로고
    • Mortality in patients with successful initial response to highly active antiretroviral therapy is still higher than in non-HIV-Infected individuals
    • A van Sighem, S Danner, AC Ghani, L Gras, RM Anderson, F de Wolf Mortality in patients with successful initial response to highly active antiretroviral therapy is still higher than in non-HIV-Infected individuals J Acquir Immune Defic Syndr 40 2005 212 218
    • (2005) J Acquir Immune Defic Syndr , vol.40 , pp. 212-218
    • Van Sighem, A.1    Danner, S.2    Ghani, A.C.3    Gras, L.4    Anderson, R.M.5    De Wolf, F.6
  • 20
    • 0141629830 scopus 로고    scopus 로고
    • Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population
    • C Jaggy, J von Overbeck, B Ledergerber Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population Lancet 362 2003 877 878
    • (2003) Lancet , vol.362 , pp. 877-878
    • Jaggy, C.1    Von Overbeck, J.2    Ledergerber, B.3
  • 21
    • 46349111534 scopus 로고    scopus 로고
    • Changes in the risk of death after HIV seroconversion compared with mortality in the general population
    • K Bhaskaran, O Hamouda, M Sannes Changes in the risk of death after HIV seroconversion compared with mortality in the general population JAMA 300 2008 51 59
    • (2008) JAMA , vol.300 , pp. 51-59
    • Bhaskaran, K.1    Hamouda, O.2    Sannes, M.3
  • 22
    • 77949401108 scopus 로고    scopus 로고
    • Late diagnosis in the HAART era: Proposed common definitions and associations with mortality
    • CA Sabin, A Schwenk, MA Johnson Late diagnosis in the HAART era: proposed common definitions and associations with mortality AIDS 24 2010 723 727
    • (2010) AIDS , vol.24 , pp. 723-727
    • Sabin, C.A.1    Schwenk, A.2    Johnson, M.A.3
  • 23
    • 85051220350 scopus 로고    scopus 로고
    • INSIGHT Strategic timing of antiretroviral treatment (START) http://insight.ccbr.umn.edu/start/ (accessed June 4, 2009).


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.